Otitis Media News and Research

RSS
Acute otitis media (AOM) is a common childhood disease with important ramifications to the overall health of infants and young children. The peak incidence of AOM occurs at 6 to 18 months of age, but it can also occur in older children. Complications of AOM include persistent middle ear effusion, chronic otitis media, transient hearing loss, or speech delays.
Cord blood vitamin D linked to pediatric RTI risk

Cord blood vitamin D linked to pediatric RTI risk

AOM associated with significant increases in direct costs incurred by consumers, health care system

AOM associated with significant increases in direct costs incurred by consumers, health care system

Implanting tubes in ears is less likely to improve long-term cognitive and functional development

Implanting tubes in ears is less likely to improve long-term cognitive and functional development

Duration of common pediatric respiratory infections estimated

Duration of common pediatric respiratory infections estimated

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

Air pollution link to early childhood pneumonia

Air pollution link to early childhood pneumonia

Smartphone-enabled otoscope provides clear images of ear tympanic membrane

Smartphone-enabled otoscope provides clear images of ear tympanic membrane

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Short-term hearing loss during childhood may lead to persistent hearing deficits

Short-term hearing loss during childhood may lead to persistent hearing deficits

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Wellcome Trust-funded study could point to new therapies for glue ear

Wellcome Trust-funded study could point to new therapies for glue ear

Common sugar molecule promising target for development of broad-spectrum vaccine

Common sugar molecule promising target for development of broad-spectrum vaccine

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Interleukin-10 levels predict otitis media culprit

Interleukin-10 levels predict otitis media culprit

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

Complications of suppurative otitis media characterized

Complications of suppurative otitis media characterized

EC approves Pfizer’s Prevenar 13 to prevent pneumococcal disease

EC approves Pfizer’s Prevenar 13 to prevent pneumococcal disease